ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FD01 | BioTech | Trastuzumab - 440mg | 8053 | 11015/1 | HERCEPTIN | 21mg/ml | 1 | Injectable concentrated powder for solution+diluent | Infusion | Omnipharma | Genentech Inc, Hillsboro, Oregon | USA | 117,147,251 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/1/2023 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FD01 | BioTech | Trastuzumab - 440mg | 10326 | 200319/1 | ARYOTRUST | 440mg | 1 | Injectable powder for concentrate for solution + solvent | Infusion | Lebiran SARL | Aryogen Pharmed | Iran | 4,913,550 L.L | 2.44 | E2 | Aryogen Pharmed | Iran | 2/1/2023 |
L01FD01 | BioTech | Trastuzumab - 440mg | 9458 | 53618/1 | HERCEPTIN | 21mg/ml | 1 | Injectable concentrated powder for solution+diluent | Infusion | Omnipharma | Genentech Inc | USA | 117,147,251 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/1/2023 |
L01FD01 | BioTech | Trastuzumab - 440mg | 10653 | 177019/1 | HERZUMA | 150mg | 1 | Injectable powder for concentrate for solution | Infusion | Droguerie Columbus | Celltrion Inc. | Korea | 1,462,608 L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 2/1/2023 |
L01FD01 | BioTech | Trastuzumab (r-DNA origin) - 440mg | 9394 | 138015/1 | MABTIN 440 | 440mg | 1+1 bacteriostatic water | Injectable powder for solution | Infusion | Benta Trading Co s.a.l. | Biocon Biologics India Limited, for Benta SAL | Lebanon | 2,378,662 L.L | 2.44 | E2 | 2/1/2023 | ||
L01FD01 | BioTech | Trastuzumab - 440mg | 10212 | 38220/1 | TRAZIMERA | 440mg | 1 | Injectable powder for solution+solvent | Infusion | Food & Drug Corporation FDC | Pfizer Manufacturing Belgium NV | Belgium | 1,813,657 L.L | 2.44 | E2 | pfizer Canada ULC | Canada | 2/1/2023 |
L01FD01 | BioTech | Trastuzumab - 440mg | 10653/945 | 177019/1 | HERZUMA | 150mg | 1 | Injectable powder for concentrate for solution | Infusion | Droguerie Columbus | Celltrion Inc. | Korea | 62,767,863.70 L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 2/1/2023 |
L01FD01 | BioTech | Trastuzumab - 440mg | 10212/945 | 38220/1 | TRAZIMERA | 440mg | 1 | Injectable powder for solution+solvent | Infusion | Food & Drug Corporation FDC | Pfizer Manufacturing Belgium NV | Belgium | 77,833,094.24 L.L | 2.44 | E2 | pfizer Canada ULC | Canada | 2/1/2023 |